Literature DB >> 21084355

The right to die in the minimally conscious state.

L Syd M Johnson1.   

Abstract

The right to die has for decades been recognised for persons in a vegetative state, but there remains controversy about ending life-sustaining medical treatment for persons in the minimally conscious state (MCS). The controversy is rooted in assumptions about the moral significance of consciousness, and the value of life for patients who are conscious and not terminally ill. This paper evaluates these assumptions in light of evidence that generates concerns about quality of life in the MCS. It is argued that surrogates should be permitted to make decisions to withdraw life-sustaining medical treatment from patients in the MCS.

Entities:  

Mesh:

Year:  2010        PMID: 21084355     DOI: 10.1136/jme.2010.038877

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  4 in total

Review 1.  The Right to Die in Chronic Disorders of Consciousness: Can We Avoid the Slippery Slope Argument?

Authors:  Rocco Salvatore Calabrò; Antonino Naro; Rosaria De Luca; Margherita Russo; Lory Caccamo; Alfredo Manuli; Alessia Bramanti; Placido Bramanti
Journal:  Innov Clin Neurosci       Date:  2016-12-01

2.  Attitudes towards end-of-life issues in disorders of consciousness: a European survey.

Authors:  A Demertzi; D Ledoux; M-A Bruno; A Vanhaudenhuyse; O Gosseries; A Soddu; C Schnakers; G Moonen; S Laureys
Journal:  J Neurol       Date:  2011-01-08       Impact factor: 4.849

3.  Relative Values: Perspectives on a Neuroimaging Technology From Above and Within the Ethical Landscape.

Authors:  Gabrielle Samuel; Alan Cribb; John Owens; Clare Williams
Journal:  J Bioeth Inq       Date:  2016-06-22       Impact factor: 1.352

4.  Structural changes in brains of patients with disorders of consciousness treated with deep brain stimulation.

Authors:  Marina Raguž; Nina Predrijevac; Domagoj Dlaka; Darko Orešković; Ante Rotim; Dominik Romić; Fadi Almahariq; Petar Marčinković; Vedran Deletis; Ivica Kostović; Darko Chudy
Journal:  Sci Rep       Date:  2021-02-23       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.